Prevention


Intensive Lifestyle Intervention Reduces Long-Term Multimorbidity in Prediabetes

US Adults with prediabetes who participated in an intensive lifestyle intervention had a significantly lower risk of developing multiple chronic diseases over 25 years, while metformin did not provide a similar benefit. This long-term follow-up of the Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS) included 1,173 […]


2026 Key Recommendations for Preventing and Managing Cardiovascular-Kidney-Metabolic Syndrome

Preventing progression and promoting regression of cardiovascular-kidney-metabolic (CKM) syndrome requires early staging, comprehensive risk assessment, management of risk factors, and use of evidence-based therapies across the life course. CKM syndrome staging is recommended for youths and adults to guide treatment and reduce cardiovascular and kidney complications. Individuals with CKM stages […]


Prediabetes Remission Confers Long-Term Protection against CVD

Achieving remission of prediabetes was associated with an approximately 50% lower long-term risk of death from cardiovascular disease (CVD) or hospitalization for heart failure, with benefits persisting for decades in two landmark diabetes prevention cohorts. In post hoc analyses of the US Diabetes Prevention Program Outcomes Study and the Chinese […]


The Surprising Gap in Heart Attack Prediction

Traditional atherosclerotic cardiovascular disease (ASCVD) risk- and symptom-based screening misses nearly half of patients under age 66 who go on to experience their first myocardial infarction (MI), revealing major shortcomings in current preventive strategies. In this US retrospective study of 465 adults presenting with a first type 1 MI, simulation […]


Secondary CVD Prevention with Colchicine

Low-dose colchicine reduces myocardial infarction and stroke in people with cardiovascular disease (CVD) without increasing serious adverse events, although it raises the risk of mild gastrointestinal symptoms and shows no clear effect on mortality or revascularization. In an updated Cochrane review of 12 randomized controlled trials including 22,983 participants followed […]


More Intensive Differential BP–Lowering Beneficial

A meta-analysis and a meta-regression of randomized clinical trials suggested that more intensive differential blood pressure (BP)–lowering may be beneficial for prevention of recurrent stroke and major cardiovascular events. The analysis included 10 randomized clinical trials comprising 40 710 patients (women 34%; mean age 65 years) with stroke or transient ischemic […]